首页> 美国卫生研究院文献>Scientific Reports >PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer
【2h】

PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer

机译:小细胞肺癌预后较差的PRC2过表达和PRC2靶基因的抑制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Small cell lung cancer (SCLC) is a subtype of lung cancer with poor prognosis. Expression array analysis of 23 SCLC cases and 42 normal tissues revealed that EZH2 and other PRC2 members were highly expressed in SCLC. ChIP-seq for H3K27me3 suggested that genes with H3K27me3(+) in SCLC were extended not only to PRC2-target genes in ES cells but also to other target genes such as cellular adhesion-related genes. These H3K27me3(+) genes in SCLC were repressed significantly, and introduction of the most repressed gene JUB into SCLC cell line lead to growth inhibition. Shorter overall survival of clinical SCLC cases correlated to repression of JUB alone, or a set of four genes including H3K27me3(+) genes. Treatment with EZH2 inhibitors, DZNep and GSK126, resulted in growth repression of SCLC cell lines. High PRC2 expression was suggested to contribute to gene repression in SCLC, and may play a role in genesis of SCLC.
机译:小细胞肺癌(SCLC)是预后较差的肺癌的一种亚型。 23例SCLC病例和42例正常组织的表达阵列分析表明,EZH2和其他PRC2成员在SCLC中高表达。对H3K27me3的ChIP-seq表明,在SCLC中具有H3K27me3(+)的基因不仅扩展到ES细胞中的PRC2目标基因,而且扩展到其他目标基因,例如细胞粘附相关基因。 SCLC中的这些H3K27me3(+)基因受到显着抑制,并且将最受抑制的基因JUB引入SCLC细胞系会导致生长抑制。临床SCLC病例的总体生存期较短与单独抑制JUB或抑制包括H3K27me3(+)基因在内的四个基因有关。用EZH2抑制剂DZNep和GSK126处理导致SCLC细胞系生长受到抑制。提示高PRC2表达有助于SCLC中的基因阻遏,并且可能在SCLC的发生中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号